YUCAIPA, Calif., Feb. 10, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading manufacturer of respiratory medical devices, recently announced that the CEO will discuss on national talk radio the progress and events leading to increased sales and revenue growth with host Steve Crowley today at 10:34AM eastern standard time on the world renowned Money Channel's American Scene Radio.
The company recently had a successful completion of Stage-I of the ISO audit that brings them just a month away from being ISO 13485 certified. With this $200,000 investment, the ISO certification closes strategic contracts and back orders of the company's Oxyview product line in China, Japan, Canada, Australia and the European Communities with projected sales of the Oxyview Smart Nasal Cannula for $10M in revenues, and the new I-Pulse Oximeter for an additional $1M in revenues in 2010.
With the near future share buy-back program and second quarter financials indicating increases in sales and corporate assets, the company is strongly committed to success and continues driving forward in a direction that is within the best interest of its shareholders.
"The hospital market has shown a steady incline in purchases of our products during this third quarter, and we are now finalizing the strategic partnerships for export distribution along with an improved national sales program," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board
About Ingen:
Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and a successful registration with the Food & Drug Administration. The company has domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the Oxyview Nasal Cannula was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010 the company introduced the Oxyview Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.